View in EDS HTML Full Text PDF Full Text

Rapamycin treatment ameliorates HLA-B27-mediated gut inflammation and alters the microbiome in experimental spondyloarthritis.

Saved in:
Bibliographic Details
Title: Rapamycin treatment ameliorates HLA-B27-mediated gut inflammation and alters the microbiome in experimental spondyloarthritis.
Authors: Van Doorn J; Pediatric Translational Research Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, Bethesda, MD, United States., Brooks SR; Biodata Mining and Discovery Section, NIAMS, NIH, Bethesda, MD, United States., LiCausi F; Pediatric Translational Research Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, Bethesda, MD, United States., Zhou K; Pediatric Translational Research Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, Bethesda, MD, United States., Betrapally NS; Laboratory of Integrative Cancer Immunology, Center for Cancer Research (CCR), NCI, National Institutes of Health (NIH), Rockville, MD, United States., Gubitz-Hess E; Pediatric Translational Research Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, Bethesda, MD, United States., Cougnoux A; Section on Molecular Dysmorphology, NICHD, NIH, Bethesda, MD, United States., Dell'Orso S; Genomic Technology Section, NIAMS, NIH, Bethesda, MD, United States., Islam S; Genomic Technology Section, NIAMS, NIH, Bethesda, MD, United States., Colbert RA; Pediatric Translational Research Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, Bethesda, MD, United States., Navid F; Pediatric Translational Research Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, Bethesda, MD, United States.
Source: Frontiers in immunology [Front Immunol] 2026 Mar 20; Vol. 17, pp. 1755132. Date of Electronic Publication: 2026 Mar 20 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41939913
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Rapamycin treatment ameliorates HLA-B27-mediated gut inflammation and alters the microbiome in experimental spondyloarthritis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Van+Doorn+J%22">Van Doorn J</searchLink>; Pediatric Translational Research Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Brooks+SR%22">Brooks SR</searchLink>; Biodata Mining and Discovery Section, NIAMS, NIH, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22LiCausi+F%22">LiCausi F</searchLink>; Pediatric Translational Research Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Zhou+K%22">Zhou K</searchLink>; Pediatric Translational Research Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Betrapally+NS%22">Betrapally NS</searchLink>; Laboratory of Integrative Cancer Immunology, Center for Cancer Research (CCR), NCI, National Institutes of Health (NIH), Rockville, MD, United States.<br /><searchLink fieldCode="AU" term="%22Gubitz-Hess+E%22">Gubitz-Hess E</searchLink>; Pediatric Translational Research Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Cougnoux+A%22">Cougnoux A</searchLink>; Section on Molecular Dysmorphology, NICHD, NIH, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Dell'Orso+S%22">Dell'Orso S</searchLink>; Genomic Technology Section, NIAMS, NIH, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Islam+S%22">Islam S</searchLink>; Genomic Technology Section, NIAMS, NIH, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Colbert+RA%22">Colbert RA</searchLink>; Pediatric Translational Research Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Navid+F%22">Navid F</searchLink>; Pediatric Translational Research Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, Bethesda, MD, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2026 Mar 20; Vol. 17, pp. 1755132. <i>Date of Electronic Publication: </i>2026 Mar 20 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41939913
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2026.1755132
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1755132
    Titles:
      – TitleFull: Rapamycin treatment ameliorates HLA-B27-mediated gut inflammation and alters the microbiome in experimental spondyloarthritis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Van Doorn J
      – PersonEntity:
          Name:
            NameFull: Brooks SR
      – PersonEntity:
          Name:
            NameFull: LiCausi F
      – PersonEntity:
          Name:
            NameFull: Zhou K
      – PersonEntity:
          Name:
            NameFull: Betrapally NS
      – PersonEntity:
          Name:
            NameFull: Gubitz-Hess E
      – PersonEntity:
          Name:
            NameFull: Cougnoux A
      – PersonEntity:
          Name:
            NameFull: Dell'Orso S
      – PersonEntity:
          Name:
            NameFull: Islam S
      – PersonEntity:
          Name:
            NameFull: Colbert RA
      – PersonEntity:
          Name:
            NameFull: Navid F
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 03
              Text: 2026 Mar 20
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 17
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1